LORANTIS
Lorantis develops products for the selective treatment of immunological and inflammatory diseases. It develops therapeutics for immunological diseases, including allergy, asthma, autoimmune diseases, and transplant regulation. The company is based in Cambridge, United Kingdom.
LORANTIS
Industry:
Health Care Health Diagnostics Medical Device
Founded:
1998-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.lorantis.co.uk
Status:
Closed
Contact:
+4401223702500
Email Addresses:
[email protected]
Total Funding:
44.01 M USD
Technology used in webpage:
Domain Not Resolving
Investors List
Quester Capital
Quester Capital investment in Series C - Lorantis
JPMorgan Partners
JPMorgan Partners investment in Series C - Lorantis
Schroder Ventures
Schroder Ventures investment in Series C - Lorantis
Wellcome Trust
Wellcome Trust investment in Series C - Lorantis
Abingworth
Abingworth investment in Series C - Lorantis
Apax Partners
Apax Partners investment in Series C - Lorantis
More informations about "Lorantis"
Lorantis - Crunchbase Company Profile & Funding
Lorantis develops products for the selective treatment of immunological and inflammatory diseases. It develops therapeutics for immunological diseases, including allergy, asthma, …See details»
Lorantis Company Profile 2024: Valuation, Investors, Acquisition ...
Developer of drugs and therapeutics for treatment of immunological diseases including allergy, asthma, autoimmune diseases and transplant regulation. The company's products are derived …See details»
Home » Laurentis Energy Partners
Project Management Organization for new nuclear Nuclear lifecycle services We have experience and expertise to help clients along the entire lifecycle of a nuclear reactor, from inspections and maintenance, to complete …See details»
Lorantis - VentureRadar
Lorantis is discovering and developing breakthrough products for the treatment of immunological and inflammatory diseases based on antigen-specific tolerance. The company's approach …See details»
Lorantis - Funding, Financials, Valuation & Investors - Crunchbase
Lorantis develops products for the selective treatment of immunological and inflammatory diseases.See details»
Lorantis - Products, Competitors, Financials, Employees, …
Lorantis is discovering and developing breakthrough products for the treatment of immunological and inflammatory diseases based on antigen-specific tolerance. Use the CB Insights Platform …See details»
Celldex Therapeutics acquires Lorantis - 2005-11-01 - Crunchbase
Nov 1, 2005 · Acquiring Organization: Celldex Therapeutics Celldex is a clinical stage company dedicated to developing monoclonal and bispecific antibodies that address devastating …See details»
Lorantis: creating new medicines for selective treatment of ...
Mar 1, 2002 · These discoveries will enable Lorantis to build a portfolio of novel drugs with the ability to treat selectively a wide range of disorders, including allergy, asthma, autoimmune …See details»
Lorantis - Abingworth LLP
Lorantis discovered and developed breakthrough products for the treatment of immunological and inflammatory diseases based on antigen-specific tolerance. The company was acquired by …See details»
Laurentis unveils new website » Laurentis Energy Partners
Dec 7, 2023 · Laurentis Energy Partners is proud to announce the launch of its new and improved website as the company continues to build on its commitments to provide exceptional customer service, deliver cutting-edge nuclear energy …See details»
Organizational Announcement - Laurentis Energy Partners
Jan 11, 2023 · Chris Ginther is named Chief Executive Officer (CEO) of Laurentis Energy Partners, and Jason Van Wart is appointed to President, effective Jan. 1, 2023. Former …See details»
Lorantis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Lorantis develops products for the selective treatment of immunological and inflammatory diseases.See details»
Lorantis: creating new medicines for selective treatment of ...
Mar 1, 2002 · Lorantis is creating new treatments for immunological diseases which target pathological responses but either do not block normal responses or affect non-immune …See details»
About Laurentis » Laurentis Energy Partners
As a commercial subsidiary of Ontario Power Generation – one of North America’s largest and most diverse clean-energy generators and innovators – Laurentis brings unparalleled real …See details»
Nuclear lifecycle services » Laurentis Energy Partners
Jul 18, 2024 · Laurentis offers a range of expertise to keep nuclear power plants running safely and efficiently, including nuclear inspection and reactor maintenance services, balance of plant …See details»
Lurantis Pokédex: stats, moves, evolution & locations
Lurantis is a Grass type Pokémon introduced in Generation 7. Lurantis draws opponents near to itself with its flowerlike appearance and aroma—and then it takes them down. It’s said to be …See details»
Project Management Organization for new nuclear
From feasibility to planning to operations, learn how Laurentis is supporting SMR projects around the world. Explore Laurentis’s suite of project management and operations services designed …See details»
Senior leadership team » Laurentis Energy Partners
Meet the people who are implementing Laurentis’s plan for strategic growth and leadership in the fields of nuclear energy services and isotope production. Jason Van Wart joined Laurentis …See details»
Newsroom - Laurentis Energy Partners
Jun 13, 2024 · From Micro Modular Reactors, to Small Modular Reactors, to new, large-scale nuclear reactor facilities, Laurentis provides end-to-end engineering and business solutions to …See details»
Project Management Organization for refurbishment
Laurentis services: OPEX and technical assistance, owner’s engineer, feasibility studies, and contract management services for OPG’s four-unit nuclear refurbishment.See details»